Trial reportHealth and quality of life outcomes2026
Individualized nutritional care including adherence support improves health-related quality of life in individuals with severe chronic obstructive pulmonary disease: a randomized controlled trial.
Trial report in Health and quality of life outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04873856 (Multidimensional INDividualized NUTritional Therapy for Individuals with Severe Chronic Obstructive Pulmonary Disease), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Multidimensional INDividualized NUTritional Therapy for Individuals with Severe Chronic Obstructive Pulmonary Disease
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUndernutrition and reduced health-related quality of life (HRQoL) are common in severe chronic obstructive pulmonary disease (COPD) and may exacerbate functional decline. This study evaluated whether individualized nutritional care with adherence support improves HRQoL in individuals with severe COPD at risk of undernutrition. Secondary outcomes included physical function, anthropometry, body composition, and dietary intake.
methodsIn this 3-month, single-center, open-label randomized controlled trial, 87 adults with severe COPD were randomized 1:1 to individualized nutritional care or standard care. The intervention comprised tailored dietary plans, adherence support (phone calls, reminders), optional oral nutritional supplements and weight diary. The primary outcome was HRQoL (EQ-5D-5 L). Secondary outcomes were disease-specific HRQoL (CAT), chair stand test, grip strength, anthropometry, body composition, and protein and energy intake. Analyses followed an intention-to-treat approach using linear mixed-effects models.
resultsOf 674 individuals screened, 91 were enrolled; of whom 87 completed the baseline visit; 44 received the intervention and 43 standard care, with 78 (90%) completing follow-up. At 3 months, the intervention improved HRQoL versus standard care (mean difference in EQ-5D-5 L utility index 0.053; 95% CI 0.003–0.103), driven by better mobility, self-care, and usual activities. Functional gains were supported by more chair stands (mean difference 0.80; 95% CI 0.05–1.55). Protein (+ 16 g/day) and energy intake (+ 326 kcal/day) increased, while no significant differences were observed in disease-specific HRQoL, anthropometry, or body composition. Benefits were greater in undernourished, frail, solitary-living participants, and men.
conclusionIndividualized nutritional care with adherence support improved HRQoL, particularly physical functioning, in individuals with severe COPD at risk of undernutrition, supporting its consideration in clinical practice.
trial registrationThe study was registered on ClinicalTrials (NCT04873856) in April 2021.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.